DC 15442
Alternative Names: DC-15442Latest Information Update: 27 Jun 2025
At a glance
- Originator DeepCure
- Class Anti-inflammatories; Antiasthmatics; Small molecules
- Mechanism of Action STAT6 transcription factor inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Asthma; Atopic dermatitis